Novavax reports strong immune responses from H5N1 avian flu vaccine candidate, showing promise in single and two-dose ...

Novavax (NASDAQ:NVAX) got good news Wednesday morning. Swissmedic, the Swiss Agency for Therapeutic Products, gave Nuvaxovid, the company’s protein-based Covid-19 vaccine, conditional marketing ...

Nuvaxovid is supplied in a single-dose prefilled syringe containing 0.5mL suspension for intramuscular injection; it should be stored in a refrigerator at 2°C to 8°C (36°F to 46°F).

GAITHERSBURG, Md., Jan. 18, 2023 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious ...

Moderna MRNA announced that the FDA has approved its supplemental biologics license application seeking approval for COVID-19 vaccine, Spikevax, for use in children aged six months to 11 years, who ...

Nuvaxovid includes an engineered fragment of the spike protein itself—albeit one without the genetic material that causes actual disease. It’s not a totally new approach to vaccine design.

GAITHERSBURG, Md., Nov. 18, 2022 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious ...

STATEN ISLAND, N.Y. — The World Health Organization (WHO) issued an emergency use listing (EUL) for another coronavirus (COVID-19) vaccine — Nuvaxovid — it was announced Tuesday. The new ...

The European Medicines Agency (EMA) on Thursday backed the use of Novavax's COVID-19 shot as a booster for adults, ahead of an anticipated rise in infections this winter. The vaccine, Nuvaxovid ...

Novavax (NASDAQ:NVAX) got good news Wednesday morning. Swissmedic, the Swiss Agency for Therapeutic Products, gave Nuvaxovid, the company’s protein-based Covid-19 vaccine, conditional marketing ...